Boule Diagnostics Stock Forward View - Simple Exponential Smoothing
| BOUL Stock | SEK 4.00 0.10 2.44% |
Boule Stock outlook is based on your current time horizon.
At this time, The value of RSI of Boule Diagnostics' share price is at 55 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Boule Diagnostics, making its price go up or down. Momentum 55
Impartial
Oversold | Overbought |
Using Boule Diagnostics hype-based prediction, you can estimate the value of Boule Diagnostics AB from the perspective of Boule Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Boule Diagnostics AB on the next trading day is expected to be 4.00 with a mean absolute deviation of 0.16 and the sum of the absolute errors of 9.80. Boule Diagnostics after-hype prediction price | SEK 4.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Boule |
Boule Diagnostics Additional Predictive Modules
Most predictive techniques to examine Boule price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Boule using various technical indicators. When you analyze Boule charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Boule Diagnostics Simple Exponential Smoothing Price Forecast For the 22nd of February
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Boule Diagnostics AB on the next trading day is expected to be 4.00 with a mean absolute deviation of 0.16, mean absolute percentage error of 0.04, and the sum of the absolute errors of 9.80.Please note that although there have been many attempts to predict Boule Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Boule Diagnostics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Boule Diagnostics Stock Forecast Pattern
| Backtest Boule Diagnostics | Boule Diagnostics Price Prediction | Research Analysis |
Boule Diagnostics Forecasted Value
In the context of forecasting Boule Diagnostics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Boule Diagnostics' downside and upside margins for the forecasting period are 0.23 and 7.78, respectively. We have considered Boule Diagnostics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Boule Diagnostics stock data series using in forecasting. Note that when a statistical model is used to represent Boule Diagnostics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.878 |
| Bias | Arithmetic mean of the errors | 0.0255 |
| MAD | Mean absolute deviation | 0.1607 |
| MAPE | Mean absolute percentage error | 0.0311 |
| SAE | Sum of the absolute errors | 9.7999 |
Predictive Modules for Boule Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Boule Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Boule Diagnostics After-Hype Price Density Analysis
As far as predicting the price of Boule Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Boule Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Boule Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Boule Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Boule Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Boule Diagnostics' historical news coverage. Boule Diagnostics' after-hype downside and upside margins for the prediction period are 0.23 and 7.77, respectively. We have considered Boule Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Boule Diagnostics is relatively risky at this time. Analysis and calculation of next after-hype price of Boule Diagnostics is based on 3 months time horizon.
Boule Diagnostics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Boule Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Boule Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Boule Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.55 | 3.77 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.00 | 4.00 | 0.00 |
|
Boule Diagnostics Hype Timeline
Boule Diagnostics is currently traded for 4.00on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Boule is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.55%. %. The volatility of related hype on Boule Diagnostics is about 0.0%, with the expected price after the next announcement by competition of 4.00. About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.06. Some equities with similar Price to Book (P/B) outperform the market in the long run. Boule Diagnostics last dividend was issued on the 6th of May 2022. The entity had 4:1 split on the 1st of June 2018. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Boule Diagnostics to cross-verify your projections.Boule Diagnostics Related Hype Analysis
Having access to credible news sources related to Boule Diagnostics' direct competition is more important than ever and may enhance your ability to predict Boule Diagnostics' future price movements. Getting to know how Boule Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Boule Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SYNACT | SynAct Pharma AB | 0.00 | 0 per month | 0.00 | (0.06) | 4.50 | (4.38) | 13.53 | |
| DMYD-B | Diamyd Medical AB | 0.00 | 0 per month | 2.16 | 0.18 | 8.69 | (3.52) | 22.62 | |
| XSPRAY | XSpray Pharma AB | 0.00 | 0 per month | 3.45 | 0.01 | 8.26 | (4.55) | 26.36 | |
| CANTA | Cantargia AB | 0.00 | 0 per month | 4.63 | 0.09 | 9.32 | (7.58) | 27.76 | |
| IBT-B | Infant Bacterial Therapeutics | 0.00 | 0 per month | 2.25 | 0.03 | 7.42 | (4.96) | 28.63 | |
| GENO | Genovis AB | 0.00 | 0 per month | 0.00 | (0.16) | 2.99 | (3.85) | 14.80 | |
| ITECH | I Tech | 0.00 | 0 per month | 0.00 | (0.17) | 4.19 | (5.00) | 24.60 | |
| BICO | BICO Group AB | 0.00 | 0 per month | 0.00 | (0.04) | 6.41 | (4.68) | 18.04 |
Other Forecasting Options for Boule Diagnostics
For every potential investor in Boule, whether a beginner or expert, Boule Diagnostics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Boule Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Boule. Basic forecasting techniques help filter out the noise by identifying Boule Diagnostics' price trends.Boule Diagnostics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Boule Diagnostics stock to make a market-neutral strategy. Peer analysis of Boule Diagnostics could also be used in its relative valuation, which is a method of valuing Boule Diagnostics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Boule Diagnostics Market Strength Events
Market strength indicators help investors to evaluate how Boule Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Boule Diagnostics shares will generate the highest return on investment. By undertsting and applying Boule Diagnostics stock market strength indicators, traders can identify Boule Diagnostics AB entry and exit signals to maximize returns.
Boule Diagnostics Risk Indicators
The analysis of Boule Diagnostics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Boule Diagnostics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting boule stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.98 | |||
| Standard Deviation | 3.71 | |||
| Variance | 13.77 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Boule Diagnostics
The number of cover stories for Boule Diagnostics depends on current market conditions and Boule Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Boule Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Boule Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Boule Diagnostics Short Properties
Boule Diagnostics' future price predictability will typically decrease when Boule Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Boule Diagnostics AB often depends not only on the future outlook of the potential Boule Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Boule Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 38.2 M |
Additional Tools for Boule Stock Analysis
When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.